山东大学教师主页岳学田 Paper Publications Home

Xuetian Yue Professor

Xuetian Yue，PhD，is a professor in Department of Cell Biology, School of Basic Medical Sciences. More+

Recommended Ph.D.Supervisor Recommended MA Supervisor

Paper Publications

Home >> Scientific Research >> Paper Publications

[1] 武专昌. cccDNA Surrogate MC-HBV-Based Screen Identifies Cohesin Complex as a Novel HBV Restriction Factor.. CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 14, 1177-1198, 2022.
[2] 李若文. P4HA2 promotes the progression of papillary thyroid cancer by enhancing degradation of IκBα to activate NF-κB signaling pathway. Cancer cell international, 25, 2025.
[3] 张召英. Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity. SCIENCE IMMUNOLOGY, 9, 2024.
[4] 任彩月. DNA Sensor ABCF1 Phase Separates With cccDNA to Inhibit Hepatitis B Virus Replication. Advanced Science, 2024.
[5] 孙敏. SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signaling. Cell Death & Disease, 15, 2024.
[6] . Urolithin A Hijacks ERK1/2-ULK1 Cascade to Improve CD8+ T Cell Fitness for Antitumor Immunity. Advanced Science, 2024.
[7] . Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse models. SCIENCE TRANSLATIONAL MEDICINE, 15, 2023.
[8] 张言坤. ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury. NATURE COMMUNICATIONS, 14, 2023.
[9] Kong, Youzi. Lipophagy-mediated cholesterol synthesis inhibition is required for the survival of hepatocellular carcinoma under glutamine deprivation. Redox Biology, 63, 2023.
[10] 王晓静. 齐鲁医学院研究生细胞生物学教学改革探索. 基础医学教育, 2021.
[11] 张晓东. TIPE1 promotes liver regeneration by enhancing ROS-FoxO1 axis mediated autophagy.. FEBS JOURNAL, 2022.
[12] 丁璐. Zhx2 maintains islet β-cell mass and function by transcriptionally regulating Pax6. iScience, 26, 106871, 2023.
[13] 王玉珍. TIM-4 orchestrates mitochondrial homeostasis to promote lung cancer progression via ANXA2/PI3K/AKT/OPA1 axis. Cell Death & Disease, 14, 2023.
[14] 焦德雁. Lipid accumulation-mediated histone hypoacetylation drives persistent NK cell dysfunction in anti-tumor immunity. Cell Reports, 42, 2023.
[15] 王樱淳. Tim-4 reprograms cholesterol metabolism to suppress antiviral innate immunity by disturbing the Insig1-SCAP interaction in macrophages. cell reports, 2022.
[16] 岳学田. SREBF2-STARD4 axis confers sorafenib resistance in HCC by regulating mitochondrial cholesterol homeostasis.. CANCER SCIENCE, 2022.
[17] 逯景辉. Multi-Omics Analysis of Fatty Acid Metabolism in Thyroid Carcinoma. FRONTIERS IN ONCOLOGY, 11, 2021.
[18] 张言坤. ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14. CANCER CELL INTERNATIONAL, 22, 2022.
[19] ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p. Journal of Pathology, 2020.
[20] Tumor suppressor ZHX2 inhibits NAFLD-HCC progression via blocking LPL-mediated lipid uptake. Cell Death and Differentiation, 2020.

TOTAL 23 PIECE 1/2

FIRSTPREVIOUSNEXT LAST PAGE

中文 | MOBILE Version | Login | SDU

Copyright All Rights Reserved Shandong University Address: No. 27 Shanda South Road, Jinan City, Shandong Province, China: 250100
Information desk: (86) - 0531-88395114
On Duty Telephone: (86) - 0531-88364731 Construction and Maintenance: Information Work Office of Shandong University

Click: Times

The Open Time: --

The Last Update Time: --

Home

Scientific Research

Teaching Research

Awards and Honours

Enrollment Information

Student Information

My Album

Blog

More

Paper Publications

[1] 武专昌. cccDNA Surrogate MC-HBV-Based Screen Identifies Cohesin Complex as a Novel HBV Restriction Factor.. CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 14, 1177-1198, 2022.

[2] 李若文. P4HA2 promotes the progression of papillary thyroid cancer by enhancing degradation of IκBα to activate NF-κB signaling pathway. Cancer cell international, 25, 2025.

[3] 张召英. Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity. SCIENCE IMMUNOLOGY, 9, 2024.

[4] 任彩月. DNA Sensor ABCF1 Phase Separates With cccDNA to Inhibit Hepatitis B Virus Replication. Advanced Science, 2024.

[5] 孙敏. SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signaling. Cell Death & Disease, 15, 2024.

[6] . Urolithin A Hijacks ERK1/2-ULK1 Cascade to Improve CD8+ T Cell Fitness for Antitumor Immunity. Advanced Science, 2024.

[7] . Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse models. SCIENCE TRANSLATIONAL MEDICINE, 15, 2023.

[8] 张言坤. ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury. NATURE COMMUNICATIONS, 14, 2023.

[9] Kong, Youzi. Lipophagy-mediated cholesterol synthesis inhibition is required for the survival of hepatocellular carcinoma under glutamine deprivation. Redox Biology, 63, 2023.

[10] 王晓静. 齐鲁医学院研究生细胞生物学教学改革探索. 基础医学教育, 2021.

[11] 张晓东. TIPE1 promotes liver regeneration by enhancing ROS-FoxO1 axis mediated autophagy.. FEBS JOURNAL, 2022.

[12] 丁璐. Zhx2 maintains islet β-cell mass and function by transcriptionally regulating Pax6. iScience, 26, 106871, 2023.

[13] 王玉珍. TIM-4 orchestrates mitochondrial homeostasis to promote lung cancer progression via ANXA2/PI3K/AKT/OPA1 axis. Cell Death & Disease, 14, 2023.

[14] 焦德雁. Lipid accumulation-mediated histone hypoacetylation drives persistent NK cell dysfunction in anti-tumor immunity. Cell Reports, 42, 2023.

[15] 王樱淳. Tim-4 reprograms cholesterol metabolism to suppress antiviral innate immunity by disturbing the Insig1-SCAP interaction in macrophages. cell reports, 2022.

[16] 岳学田. SREBF2-STARD4 axis confers sorafenib resistance in HCC by regulating mitochondrial cholesterol homeostasis.. CANCER SCIENCE, 2022.

[17] 逯景辉. Multi-Omics Analysis of Fatty Acid Metabolism in Thyroid Carcinoma. FRONTIERS IN ONCOLOGY, 11, 2021.

[18] 张言坤. ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14. CANCER CELL INTERNATIONAL, 22, 2022.

[19] ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p. Journal of Pathology, 2020.

[20] Tumor suppressor ZHX2 inhibits NAFLD-HCC progression via blocking LPL-mediated lipid uptake. Cell Death and Differentiation, 2020.